Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15149 ↗At a glance
Journal article in Clinical Transplantation, 2023. Written by Jessica Newman and 10 co-authors. Institution: Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA. Major MEDLINE topics: Tacrolimus, Kidney Transplantation. 18 references.
Abstract (original language)
Outcomes analyzing conversion from IR‐tacrolimus (IR) to LCP‐tacrolimus (LCP) in obesity are limited. This was a retrospective longitudinal cohort study of patients converted from IR to LCP from June 2019 to October 2020. Primary outcomes were conversion ratios for weight‐based dose at a steady‐state therapeutic level and identification of appropriate dosing weight. Other outcomes included tacrolimus coefficient of variation (CV), time in therapeutic range (TITR), adverse events, infections, donor specific antibodies (DSAs), and acute rejection. A total of 292 patients were included; 156 and 136 patients with a BMI < 30 and BMI ≥ 30 kg/m 2 , respectively. Baseline characteristics were similar, except for pancreas transplant, diabetes, and HLA mismatch. IR to LCP conversion ratio ranged from .73 to .79. Mean LCP dose was similar (.08 vs. .07 mg/kg/day for BMI < 30 and BMI ≥ 30 kg/m 2 , respectively); there was a significant difference in IR and LCP mg/kg dosing at steady state with TBW (.11 mg/kg vs.09 mg/kg and .08 mg/kg vs. .06 mg/kg, respectively). The most appropriate dosing weight was adjusted body weight (AdjBW), consistent across IR and LCP steady‐state doses, and might yield more accurate steady‐state dosing requirements. In multivariable modeling, BMI was a significant predictor of steady state mg/kg dosing at therapeutic goal for total body weight (TBW), but not ideal body weight (IBW) or AdjBW.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Pharmacy, Ralph H Johnson VAMC, Charleston, South Carolina, USA.
ORCID profiles: Jessica Newman, Neha Patel, Shikha Patel, David Taber
Cite
APA
Newman, J., Patel, N., Patel, S., Sprague, T., Bartlett, F., Rao, N., Andrade, E., Rohan, V., DuBay, D., Casey, M. J., & Taber, D. (2023). Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15149
Vancouver
Newman J, Patel N, Patel S, Sprague T, Bartlett F, Rao N, et al. Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15149
BibTeX
@article{Newman2023,
author = {Newman, Jessica and Patel, Neha and Patel, Shikha and Sprague, Taylor and Bartlett, Felicia and Rao, Nikhil and Andrade, Erika and Rohan, Vinayak and DuBay, Derek and Casey, Michael J and Taber, David},
title = {Impact of obesity on the conversion of immediate‐release tacrolimus to extended‐release tacrolimus in kidney transplant recipients},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15149}
}
EUVIMED